Using a murine challenge model, we previously determined that human papillomavirus (HPV) pseudovirions initially bind preferentially to the cervicovaginal basement membrane (BM) at sites of trauma. We now report that the capsids undergo a conformational change while bound to the BM that results in L2 cleavage by a proprotein convertase (PC), furin, and/or PC5/6, followed by the exposure of an N-terminal cross-neutralization L2 epitope and transfer of the capsids to the epithelial cell surface. Prevention of this exposure by PC inhibition results in detachment of the pseudovirions from the BM and their eventual loss from the tissue, thereby preventing infection. Pseudovirions whose L2 had been precleaved by furin can bypass the PC inhibition of binding and infectivity. Cleavage of heparan sulfate proteoglycans (HSPG) with heparinase III prevented infection and BM binding by the precleaved pseudovirions, but did not prevent them from binding robustly to cell surfaces. These results indicate that the infectious process has evolved so that the initial steps take place on the BM, in contrast to the typical viral infection that is initiated by binding to the cell surface. The data are consistent with a dynamic model of in vivo HPV infection in which a conformational change and PC cleavage on the BM allows transfer of virions from HSPG attachment factors to an L1-specific receptor on basal keratinocytes migrating into the site of trauma.furin ͉ HSPG ͉ mouse model ͉ proprotein convertase P apillomaviruses (PVs) infect mucosal and cutaneous stratified squamous epithelia, resulting in benign lesions, some of which can progress to invasive cancer. Human papillomavirus (HPV) 16 and several other PVs that preferentially infect the anogenital mucosa are responsible for virtually all cases of cervical cancer, as well as a number of other mucosal epithelial malignancies. It has been recognized for decades that efficient induction of experimental PV infection of animals requires local wounding in conjunction with virus exposure (1-4). However, there has been little molecular insight into the in vivo steps by which PVs initiate the infectious process.We recently described a murine cervicovaginal challenge model of PV transmission that is amenable to examination of the early in vivo events of PV infection (5, 6). It employs high titer PV pseudoviruses, which are authentic PV capsids composed of the L1 major and L2 minor structural proteins that have encapsidated a non-PV plasmid encoding a quantifiable reporter gene to monitor successful infection (7). PV pseudoviruses abrogate the exquisite species specificity of the viral gene expression program of authentic PV virions, while retaining the early events of PV infection, including the preferential infection of keratinocytes in vivo. In the initial characterization of the mouse genital tract model, we confirmed that wounding by the transient disruption of cervicovaginal epithelial integrity, by physical or chemical means, is essential for efficient infection (5). It was shown that ...